Category Archives: Health

What is new in the field of Health. Trending topics, and cutting edge research in the are of Health. Press Releases that give us updates on Health.

Lifestyle: Self Help

IV DRIPS Customized IV Hydration & Wellness Now Offering Sacramento, CA, Residents Premier Mobile Intravenous Therapy Service

Leave a comment



IV DRIPS is excited to provide concierge, on-demand in-home drips, hydration drips, hangover drips, immunity drips and more to clients in Sacramento.

SACRAMENTO, Calif., Dec. 4, 2023 /PRNewswire-PRWeb/ — IV DRIPS Customized IV Hydration & Wellness is thrilled to announce its expansion into the Sacramento area. With a mission to enhance health and well-being, IV DRIPS is now offering concierge, on-demand, in-home drips to clients in Sacramento and its surrounding areas. This premier mobile IV therapy service provides clients with proprietary IV infusion blends that are loaded with essential fluids, electrolytes, vitamins and antioxidants designed to promote whole-body health. Everyone has experienced days when they do not feel their best. Whether the flu or a few too many cocktails the night before are affecting well-being, there is no reason to suffer. IV DRIPS’ expansion into Sacramento comes at a time when the demand for mobile wellness services is on the rise. The convenience and effectiveness of IV hydration therapy have gained popularity among individuals seeking quick and efficient solutions to their health concerns. Delivering hydration & nutrients via IV means clients get 100% absorption of these essential elements delivered directly to the cells through the bloodstream. Depending on the desired result, IV DRIPS has several different customizable IV drip formulas to choose from to restore fluid levels and vitamins, electrolytes, minerals, amino acids and other nutrients directly to the bloodstream, increasing energy, boosting health, cleansing and hydrating instantly. IV DRIPS Customized IV Hydration & Wellness also offers focused drip formulas for prenatal, migraines, food poisoning, detox, vitality and a specialized NAD+ infusion, which can improve health down to the cellular level. During an appointment, a nurse will come to a client’s residence or location to complete the treatment. The qualified staff at IV DRIPS are trained to medically evaluate clients before starting and provide painless, effective IV drip therapy, which typically takes only 30-45 minutes. When a body or brain boost is necessary, IV therapy drips and infusions in Sacramento, CA, are now just a call away, bringing clients direct, customized IV therapy.

Health

Creators Entertainment Group Celebrates Transformative Brand Partnerships, Achieving Remarkable Results, Exceptional Performance, and Unparalleled Growth Capabilities.

Leave a comment


Creators Entertainment Group (CEG), The Creative Agency of the Future, is setting a new standard in healthcare marketing partnerships.

NEW YORK, Dec. 4, 2023 /PRNewswire-PRWeb/ — Creators Entertainment Group (CEG), The Creative Agency of the Future, is setting a new standard in healthcare marketing partnerships. As a trailblazer in the influencer marketing industry, CEG is redefining brand collaborations aimed at making a positive impact on lives.

CEG goes beyond conventional influencer marketing by designing and executing influencer-powered brand partnership campaigns for social good. One notable example is the collaboration between Eli Lilly and Hip Hop Artist Rob Base. Together, they unveiled an impactful campaign focused on raising awareness and educating healthcare professionals and adults about kidney disease. Base’s iconic 1998 hit song “It Takes Two” was re-recorded to emphasize the importance of comprehensive kidney testing through blood and urine samples. Rob Base, now 56 and having experienced the loss of his friend and musical partner, urges proactive health checks.

In another impactful healthcare partnership, CEG collaborated with Jovi, a brand dedicated to freeing women from pain with an innovative, reusable pain relief patch. To honor and support Breast Cancer Awareness Month, Jovi created a special pink patch for those who are currently or have previously suffered from Breast Cancer. Jovi’s BCA campaign and the pink patch created for post-mastectomy relief were a phenomenal success. For every patch sold, Jovi generously donated a product to breast cancer patients, resulting in a sold-out campaign and widespread acclaim.

CEG is making a resolute commitment to healthcare by fostering brand partnerships that make a meaningful impact and drive success through authentic talent promotion. With an unwavering dedication to excellence and innovation, CEG values impactful partnerships that contribute to the betterment of society and support the ongoing growth and prosperity of its partners.

About Creators Entertainment Group:

Creators Entertainment Group (CEG) has been the leading creator agency in the country for the last 25 years. At CEG, we infuse authenticity, transparency, and genuineness into campaign strategies for targeted growth through brand partnerships and creator collaborations. For more information, visit www.cegtalent.com

Media Contact

Toni Mattia, Creators Entertainment Group, 1 (212) 921-2190, [email protected]

SOURCE Creators Entertainment Group

Health

Paris Baguette Continues To Dominate the Bakery Franchise Industry, Signs Agreement in Roseville, MN for One Location

Leave a comment


With 109 freshly signed deals and over 40% year-over-year growth, Entrepreneur Magazine’s No. 1 bakery/cafe brand is poised to meet, if not exceed, its goal of 64 units opened in 2023, expanding to Florida, Hawaii, Maryland and more.

ROSEVILLE, Minn., Dec. 4, 2023 /PRNewswire-PRWeb/ — Paris Baguette, the bakery café concept with 4,000 units worldwide including nearly 150 in the United States, has seen significant growth in the past year. After a remarkable 2022 and strong end of 2023, the franchisor is continuing along an impressive growth trajectory with its most recent signing in Roseville, MN.

“We are thrilled to announce additional expansion within Minnesota. There’s a tremendous amount of opportunity in the bakery café space,” explained Eric Lavinder, Chief Development Officer. “No other bakery café franchisors are doing what Paris Baguette is on the same scale. Our ability to stay true to our bakery café roots while embracing aggressive expansion has garnered attention, and that only serves to drive us forward.”

The Roseville deal will bring the total number of locations within Minnesota to one. The agreement was signed by Wendy Yang & Hongkong Vang who are pioneering the additional growth.

“When looking for the right franchise opportunity, Paris Baguette was the ideal fit because of its amazing product line, store design and proven response from communities throughout the United States,” said Yang.

Moving forward, the brand continues to eye the 1,000 unit mark within the U.S. by 2030, and as it continues to grow, Lavinder explained that Paris Baguette seeks passionate franchisees interested in serving people in a welcoming neighborhood establishment.

“We want someone who is going to take the time to put the right staff members in place in their store and ensure everyone understands the most important person is the guest,” he added.

Within the $17 billion bakery segment, Paris Baguette continues to differentiate itself by offering breads, cakes and pastries made fresh daily, unlike many other concepts that primarily offer soups, salads and other pre-made goods.

For franchisees looking to break into the industry, Paris Baguette provides remarkable brand recognition, unique guest offerings and strong franchisee support while maintaining its commitment to following a true bakery café model.

In 2023, Paris Baguette aims to sign 160 franchise agreements and open 64 new cafés. Lavinder said target markets for the coming year include Washington, California, Arizona, Colorado, Minnesota, Kansas, Oklahoma, Texas, Missouri, Wisconsin, Illinois, Tennessee, Georgia, Florida, North Carolina, South Carolina, Kentucky, West Virginia, Virginia, Ohio, Indiana, Michigan, Pennsylvania and Maryland. He added that the brand will continue its development in New Jersey and New York and expand in some additional states in New England, including Connecticut and Massachusetts.

“We are on track to enter 45 new markets and open a total of 64 units by the end of 2023,” said TJ Rogers, franchise sales manager. “Even throughout the pandemic and its aftershocks, we did not shy away from opening additional units and exploring new markets. With great year-over-year revenue increases and a persistent interest in the brand from franchisees and consumers alike, we expect nothing but a strong continued growth trajectory for the brand.”

The total investment to franchise with Paris Baguette ranges from $652,565 and $1,750,900 including a $50,000 franchise fee. For more information, please visit https://parisbaguette.com/franchising/.

ABOUT PARIS BAGUETTE
Paris Baguette is a bakery café franchise with more than 4,000 units across the globe. The global brand first franchised in the U.S. in 2015 and has since established nearly 150 locations in markets across the country, making it one of the premier franchise opportunities in its category. Paris Baguette’s primary mission, executed every day by its expert staff of bakers, cakers and baristas, is to share moments of joy with guests and help guests share moments of joy with their friends and family by providing world-class cakes, pastries, coffees, breads and other French-inspired bakery café fare. To find out more information on costs to buy this franchise, please visit https://ownaparisbaguette.com/.

Media Contact

Julie Maw, Mainland, 3125263996, [email protected], www.hellomainland.com

SOURCE Paris Baguette

Health

Alucio™ Unveils Beacon Hub 2.0 to Further Elevate HCP and Stakeholder Engagement

Leave a comment


These improvements include the ability for MSLs to highlight key sections of the content that they have uploaded to Beacon Hub. This in turn activates automated pointers or bookmarks for HCPs, enabling them to jump directly to those highlighted content sections without having to wade through entire documents.

In addition, there are now new collaboration capabilities designed for Medical Communications Teams to create shareable Hubs around disease areas, congress meetings, or important educational initiatives and then publish those Hubs to MSLs for approved external distribution. This capability can also be very helpful for Medical Information teams wanting to disseminate critical product-related content packets in a real-time manner.

Furthermore, within Beacon Hub, designated HCPs now have the capability to upload their own documents, such as presentation slides or research reports, and share additional resources like journal article links or social media posts with MSLs and life science companies. This secure feature fosters additional collaboration and information exchanges between HCPs and the company on key scientific topics or research.

All of these new enhancements in Beacon Hub are fully customizable and configurable according to individual customer business needs and compliance guidelines.

“We are committed to delivering cutting-edge engagement and collaboration capabilities to provide meaningful benefits to our Beacon customers,” shared Eric Chen, Alucio’s Chief Technology Officer. “With this enhanced release of Beacon Hub, field users will be able to conduct deeper and extended scientific exchanges with the KOLs they are interacting with.”

“It is really exciting to see these meaningful, new enhancements in Beacon Hub as part of the broader Beacon platform,” echoed Nika Sajed, Principal Medical Scientist at Gilead. “In field medical, we are always looking for creative ways to extend the scientific conversation with HCPs. Beacon Hub is a very unique and flexible solution that allows MSLs and Medical Affairs teams to respond to stakeholder needs, increase connectivity and deepen relationships.”

About Alucio:
Alucio is dedicated to the development of innovative software applications specifically for the life sciences industry. Alucio’s flagship product, Beacon, is a modern, cloud-based scientific exchange platform that enhances scientific dialogue and engagement between life science companies and healthcare professionals. For more information, please visit the company’s website at http://www.alucio.io or contact Lisa Amin at [email protected] (925) 788-3533.

Media Contact

Lisa Amin, Alucio, 925-788-3533, [email protected], https://www.alucio.io

SOURCE Alucio

Health

Wendy Webber Nelson, PhD and Michael Patsalos-Fox Join SciShield’s Board of Directors

Leave a comment


Industry Luminaries Bring Expertise and Leadership

SAN FRANCISCO, Dec. 4, 2023 /PRNewswire-PRWeb/ — SciShield, a leading provider of safety and regulatory compliance management software for scientific laboratories, today announced that Wendy Webber Nelson, PhD and Michael Patsalos-Fox have joined its Board of Directors. Both bring decades of experience in corporate leadership and the life sciences industry.

“I am excited to welcome Dr. Wendy Webber Nelson and Michael Patsalos-Fox to the SciShield Board of Directors. Wendy and Michael bring a depth of expertise and customer focus that’s truly inspiring, said Nathan Watson, Founder & CEO of SciShield. “I’m looking forward to collaborating with them to enrich our strategic initiatives and deliver even more scientific innovation to our customers.”

Wendy is the President and Founder of the Boston Biotech Forum, an executive networking group created in 2011 to address pertinent industry topics with executive leaders and technical experts that has expanded to include over 300 leading biopharma companies around the world. Additionally, Wendy serves as the Chief Business Officer for Danforth Advisors, acts as an advisor for Dreavent Capital and Modern Vivo, and is a Venture Partner at Waterman Ventures. Previously, Wendy was CEO of LeadingBiotech, held senior business development or operational roles at Frontage Laboratories, inVentiv, Worldwide Clinical Trials, QPS, Alantos Pharmaceuticals, and Alkermes. Wendy is also an inventor on multiple patents and the senior author of numerous scientific publications.

“I am thrilled to join the SciShield team and expand usage of its laboratory safety compliance and sample inventory management tools in our industry at a time when efficient use of capital is critical, ” said Wendy Webber Nelson.

Michael is the Chair of MIO Partners and serves on the board of directors for Cognizant. He is the former Chairman of the Board and CEO of Vidyo, Inc., a video telehealth platform provider. Previously, Michael was the CEO of Stroz Friedberg, Inc., a global cybersecurity firm and was a Senior Partner at McKinsey & Company where he worked for 32 years. During his tenure at McKinsey, Michael served on the Board of Directors for 12 years, served on the firm’s Operating Committee, and led the Americas Region, the New York and New Jersey offices, the North American Corporate Finance and Strategy practice and the European Telecoms practice.

“I am excited to be working with Nathan and the team to grow SciShield as it becomes ever more critical to the safe, orderly and high integrity in management of lab resources, especially in the new world of environmental awareness and regulation”, said Michael Patsolos-Fox.

“We’re thrilled to welcome Wendy and Michael to the SciShield Board of Directors,” said Neil Willis, member of the SciShield Board of Directors and Partner at Strattam Capital. “Their commitment to excellence aligns seamlessly with SciShield’s unwavering dedication to improving the health, safety and efficiency of scientists everywhere and we look forward to their contributions.”

About SciShield

SciShield reduces burden on scientists worldwide while increasing safety, regulatory compliance, and operational efficiency for their organizations through our modular, enterprise software solutions. SciShield’s customers range from biotechs and life science incubators to over a third of the top-tier (R1) research institutions, and top-10 pharmaceutical companies. Free your scientists from the burden with SciShield.com.

Media Contact

Kimberley Kasper, Strattam Capital, 1 4152302705, [email protected], Strattam Capital

SOURCE SciShield

Health

RT MicroDx Founder & CEO Nathalya Mamane to Present at New England Venture Summit

Leave a comment


RT MicroDx is working to develop a platform technology to bring molecular diagnostics for common infectious diseases into consumers’ homes. As a first use case, Mamane and her team have selected the use of saliva and the detection of Strep A infection; they are planning to develop similar home diagnostic tests for RSV, mononucleosis, meningococcal disease, staphylococcus, haemophilus influenzae, and more in the future. Previous studies (not conducted by RT MicroDx) have proven that saliva is an adequate vector for detecting strep using DNA amplification, and RT MicroDx has developed a patented, first-of-its-kind technology that, if approved, will allow for a simple, binary, positive/negative strip readout without the need for expensive laboratory equipment, advanced health literacy, or access to technology to interpret results at home.

“Current molecular diagnostic tests are either lab tests that require taking time off work, getting a doctor appointment, and traveling to the doctor’s office – not to mention the high costs of health insurance and copays – or they are at-home tests (for COVID-19 and flu only) that are cost prohibitive. And for Strep A, there are no at-home tests at all,” Mamane explained. “This just isn’t sustainable. We need diagnostic options that are accessible for everyone. We need a better way.”

RT MicroDx has completed proof-of-concept studies for its Strep A test and is currently seeking capital in order to submit for FDA approval to begin first-in-human trials. The company has previously earned recognition as a runner-up in the 2022 MIT Launch Challenge, first place winner in the Blank Center for Entrepreneurship at Babson College “Babson Entrepreneurial Thought & Action” challenge, a finalist in the Mass Challenge US Early Stage Cohort 2022, and a finalist in the Mass Innovation Eddies Cohort 2023. Mamane and RT MicroDx have also been featured in Axios, GenomeWeb, and Boston Business Journal.

RT MicroDx’s technology and diagnostic tests are in prototype stage and have not been evaluated or approved by the FDA.

To schedule a meeting with Mamane at the New England Venture Summit, email: [email protected].

About RT MicroDx

RT MicroDx is a biotech company working to develop a technology platform for affordable, accurate, at-home molecular diagnostics for common infectious diseases. We are a woman-owned, minority-owned business, driven by our passion to make diagnostics affordable and accessible to all. High costs of healthcare, social determinants of health, economic disparities, and physician shortages have combined to form the perfect storm to make our current way of delivering healthcare in the US unsustainable. We’re working to find a better way. To learn more, visit https://rtmicrodx.com/.

Media Contact

Jennifer Ringler, RT MicroDx, 1 973-647-5004, [email protected], https://rtmicrodx.com/ 

SOURCE RT MicroDx

Health: Psychology

Xtalks Announces its Life Science Webinar Calendar for December 2023

Leave a comment


Upcoming free, educational webinars from Xtalks will feature topics on cell and gene therapy, clinical trials, commercialization & HEOR, drug discovery & development, fundamental research, healthcare, laboratory technology, medical device, patient recruitment & retention, pharma manufacturing & supply chain and preclinical.

TORONTO, Dec. 4, 2023 /PRNewswire-PRWeb/ — Stay on top of current hot topics through free webinars presented by leading experts in the pharma, biotech, medical device and food industries. Access to all webinars is free, so be sure to register today to save your place! Participate in the discussion and stay relevant in your field!

Visit http://www.xtalks.com to see our upcoming webinars:

CELL AND GENE THERAPY
December 1– Adoptive Cell Therapy in Oncology: Key Considerations and Developments

CLINICAL TRIALS
December 4– Clario’s Oncology Webinar Series
December 4– Unlocking Dry Eye Innovation with The Latest Clinical Designs and Technologies
December 4– Three Key Strategies to an Optimal Functional Service Provider (FSP) Partnership
December 5– Easing the Challenges of Global Feasibility: Strategies to Balance Priorities, Manage Disparate Data Sources and Mitigate Risk
December 6– See How it’s Done: Case Studies on Patient Experience Design
December 7– Amplifying Evidence with Unified Clinical Trial Data Collection
December 8– Endpoints for Neuroprotection in Glaucoma Trials
December 11– Navigating Industry Needs for Retina Therapy Clinical Research Success
December 12– Are Regulators Driving or Impeding Innovation in Clinical Trials?
December 18– How to Accelerate Lupus Solutions with RWD
December 19- 10 Things You Didn’t Know About Decentralized Clinical Trials

COMMERCIALIZATION & HEOR
December 11– From Vanity Metrics to Valuable Insights: Unveil Your Marketing Impact

DRUG DISCOVERY & DEVELOPMENT
December 5– Powering the AI Revolution for Drug Discovery with High-Quality Empirical Data
December 6– The Impact of GLP-1s on Cardiovascular Clinical Development
December 6– Digital Strategies to Accelerate Modern Biopharmaceutical Process Development
December 7– FDA Oncology Center of Excellence: Programs & Projects That Impact Drug Development
December 18– Inhaled Biologics: Formulation, Analysis and Regulation
December 18– Vaccine Clinical Development: Key Ingredients to Improve Efficiency

FUNDAMENTAL RESEARCH
December 1– Psychedelics 3.0: Challenges and Opportunities in a Rapidly Evolving Field
December 8– Strategies to Prevent Contamination in a Cell Culture Lab
December 13– Artificial Intelligence in Chemistry: Opportunities, Trends and Challenges

HEALTHCARE
December 1– Holistic Measures of Physical Functioning in Cancer: New Opportunities with Digital Health Technologies
December 4– Personalizing Healthcare with Digital Technologies

LABORATORY TECHNOLOGY
December 8– Bispecific Antibodies: Structural Design, Production and Purification Strategies
December 11– A Rapid Single Cell Cloning Workflow for Antibody Discovery from Rabbits: A Case Study
December 18– Breast Cancer Multiomics: Unified Insights in Tumor Heterogeneity

MEDICAL DEVICE
December 6– Navigating SaMD and SiMD: Real-World FDA Regulatory Strategies for Medical Device Software

PATIENT RECRUITMENT & RETENTION
December 5– New Approaches to Adherence and Prevention of Dropouts: The Digital Era of Patient Engagement

PHARMA MANUFACTURING & SUPPLY CHAIN
December 5– Warehouse Automation Within the Pharmaceutical Industry: Logistics from Dock to Dock
December 14– Ahead of the Curve: Formula for Pharmaceutical Logistics and Supply Chain Success in 2024
December 14– Unleashing the Potential of ADCs with High-Quality Bioreagents

PRECLINICAL
December 12– Risk Assessment of Novel Neurotherapeutics: Mechanistic Translation of Preclinical Safety and PK/PD Data to a Clinical Setting

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://www.xtalks.com. 

Media Contact

Ayesha Rashid, Xtalks, +1 (416) 977-6555 x272, [email protected]

SOURCE Xtalks

Health: Mental Health

How to Accelerate Lupus Solutions with RWD, Upcoming Webinar Hosted by Xtalks

Leave a comment


  • Demographic and socioeconomic data
  • Deep clinical information on disease manifestations
  • Health care utilization, including treatment information
  • Long-term clinical outcomes, including patient-reported outcomes (PROs)

Join Alira Health’s Real World Solutions experts and external partners from FORWARD — the US national databank for rheumatic diseases — for a deep dive into Lupus RWD.

Join Dr. Kaleb Michaud, Professor, Division of Rheumatology, Director, Rheumatology Fellowship Research Program, University of Nebraska Medical Center; Dr. Patti Katz, Professor, Medicine, University of California San Francisco; and Frederico Calado, Vice President, Global Real-World Solutions, Alira Health, for the live webinar on Monday, December 18, 2023, at 11am EST (4pm GMT/UK).

For more information, or to register for this event, visit How to Accelerate Lupus Solutions with RWD.

To learn more about the Alira Health partnership with FORWARD, visit Alira Health and FORWARD Launch Enhanced Lupus Patient Registry, Accelerating Solutions for Patients.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars and digital content to the global life science, food, healthcare and medical device communities. Every year, thousands of industry practitioners (from pharmaceutical, biotechnology, food, healthcare and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps professionals stay current with industry developments, regulations and jobs. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Media Contact

Vera Kovacevic, Xtalks, +1 (416) 977-6555 x371, vkovacevic@xtalks.com

SOURCE Xtalks

Health: Addiction

Ideal Option Opens Largest Addiction Medicine Center in Yakima

Leave a comment


The new, high-capacity clinic will vastly increase the number of individuals in active treatment and recovery from substance use disorder.

YAKIMA, Wash., Dec. 4, 2023 /PRNewswire-PRWeb/ — Ideal Option, a national leader in evidence-based outpatient treatment for addiction to fentanyl, heroin, methamphetamine, alcohol and polysubstance, has opened a new addiction medicine center in Yakima.

The new center merges their two existing Yakima clinics at 11th Ave and River Rd into one location at 602 N 39th Ave. Located in the same building as Yakima County Medical Society, the center is staffed with three addiction medicine providers and five medical assistants and patients receive support from a peer outreach specialist. With capacity to see up to 75 patients per day, the clinic is the largest of its kind in Yakima.

A trusted, low-barrier provider in Yakima for over 10 years, Ideal Option carries no waitlists, accepts Medicaid and serves all patients with respect and dignity. Ideal Option providers are experts in treating high-risk patients who need specialized protocols for complex drug combinations or health conditions such as pregnancy and chronic disease.

Ideal Option data support the effectiveness of medication-assisted treatment for opioid use disorder. Among Washington state patients who continued treatment with Ideal Option throughout 2022, urine drug testing revealed a remarkable 98% reduction in fentanyl use and a 94% reduction in total opioid use.

With the recent expansion of its in-house laboratory capabilities, Ideal Option is now able to detect dozens of fentanyl analogs, nitazines, novel psychoactive substances, and cutting agents such as xylazine and lidocaine – information used to guide personalized treatment plans.

According to data from the Yakima County Coroner’s Office, 98 residents died of a drug overdose last year, a 34% increase from the 73 deaths reported in 2020. Of the overdose deaths that occurred in 2020 and 2021, more than 60% involved opioids, with fentanyl being the most common opioid involved in those deaths.

“Yakima has been hit particularly hard by the street drug epidemic, so a high-capacity centralized, low-barrier resource like this is desperately needed,” said Tyler Vermillion, Ideal Option community outreach coordinator for Eastern Washington. “We hope this beautiful new center will help to normalize treatment and encourage more people suffering from substance use disorder in Yakima County to begin their recovery and reclaim their lives.”

The new treatment center in Yakima is open Monday – Thursday, 7:00 a.m. – 6 p.m. at 602 N 39th Ave, Ste. 200.

Most forms of insurance are accepted, including Medicare and Medicaid, and patients can typically get started on treatment for fentanyl, heroin, alcohol or other substances within 1-3 business days.

Ideal Option’s offices on 11th Ave and River Rd have now closed.

Patients can make an appointment by calling 1.877.522.1275 or visiting‥www.idealoption.com.

About Ideal Option

Headquartered in Kennewick, Washington, Ideal Option was founded in 2012 and has since helped more than 75,000 patients through a network of 89 office-based medication-assisted treatment (MAT) clinics across 9 states. With a mission to serve under-served communities, Ideal Option accepts most forms of insurance including Medicaid and Medicare. Financial assistance and payment plans are also available.

Ideal Option’s team of medical providers carry certifications in Addiction and Emergency Medicine, Internal, and Family Medicine, among other specialties. The company also employs social workers, caseworkers, counselors, and mental health practitioners. This holistic approach helps drive positive outcomes, including family stability, stable housing, improved overall health, and reduced rates of recidivism.

In all the communities it serves, Ideal Option collaborates with existing stakeholders and providers to improve the continuum of care. This approach includes partnerships with emergency rooms and county jail systems, where individuals with substance use disorder often appear, as well as collaborating with numerous support agencies and municipal programs addressing social needs such as housing, mental health, and nutrition support.

Media Contact

Olivia Roe, Ideal Option, 1 9199466644, [email protected], www.idealoption.com

Twitter, Facebook, LinkedIn

SOURCE Ideal Option



Health

Claire Fair Joins Cardiovascular Logistics as the Company’s Chief People Officer

Leave a comment


“We’re thrilled to welcome Claire to Cardiovascular Logistics. She is an exceptionally talented human resources leader who brings a unique passion for driving change and transformation, improving performance, and supporting the goals of high-growth organizations in the healthcare and service industries,” said David Konur, CEO of Cardiovascular Logistics. “Her strong ability to collaborate between business and human resources to steer company strategy and direction will be instrumental in meeting our evolving business needs and positioning us for sustained growth.”

Fair comes to Cardiovascular Logistics with a wealth of experience, having served as the Senior Vice President and Chief People Officer at Pediatrix Medical Group for 21 years. During her tenure, she contributed to the growth of the organization from 1,400 to 15,000 employees, led the cultural integration of acquired physician practices and new specialties, championed diversity initiatives, and hired the first diversity, equity, and inclusion leader in the organization. Before her role at Pediatrix Medical Group, Fair served as the Vice President of Human Resources for Perfumania, leading the HR function as the company grew from 125 stores and became the nation’s largest discount retailer of fragrances, cosmetics, and related products with approximately 265 stores, an e-retail site, and a workforce of more than 1600 employees.

“Cardiovascular disease is on the rise, driven by factors such as the aging population, rising obesity rates, and individuals grappling with the long-haul effects of COVID-19. With its rapidly expanding national platform, Cardiovascular Logistics has the incredible potential to ensure cardiovascular patients receive the highest quality of care,” said Fair. “I’m excited to join this exceptional organization at this foundational stage and look forward to contributing to the well-being of thousands of patients by supporting our most valuable asset—our people.”

Fair holds a bachelor’s degree in Fashion Merchandising/Retail Management from Central Washington University in Ellensburg, Wash.

About Cardiovascular Logistics

Cardiovascular Logistics (CVL) is the most comprehensive cardiovascular platform in the country. Formed in 2013, CVL is integrating the nation’s best cardiology practices into one robust cardiovascular solution. CVL is fundamentally changing how cardiovascular care is delivered in the United States. The CVL platform is grounded in the mission of providing patients with the highest quality of cardiovascular care available. CVL partners with Lee Equity Partners, a New York-based private equity firm. For more information, visit www.cardiovascularlogistics.com.

Media Contact

Elizabeth Mars, Marketri, 1 303.955.0319, [email protected], www.marketri.com

SOURCE Cardiovascular Logistics